UA76168C2 - COMPOUNDS BEING DRASTIC INHIBITORS OF Na+/Ca+2 EXCHANGE MECHANISM IN TREATMENT OF ARRHYTHMIA - Google Patents

COMPOUNDS BEING DRASTIC INHIBITORS OF Na+/Ca+2 EXCHANGE MECHANISM IN TREATMENT OF ARRHYTHMIA Download PDF

Info

Publication number
UA76168C2
UA76168C2 UA2004020928A UA2004020928A UA76168C2 UA 76168 C2 UA76168 C2 UA 76168C2 UA 2004020928 A UA2004020928 A UA 2004020928A UA 2004020928 A UA2004020928 A UA 2004020928A UA 76168 C2 UA76168 C2 UA 76168C2
Authority
UA
Ukraine
Prior art keywords
yloxy
chroman
phenylchroman
nmr
dmso
Prior art date
Application number
UA2004020928A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of UA76168C2 publication Critical patent/UA76168C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
UA2004020928A 2001-07-10 2002-10-07 COMPOUNDS BEING DRASTIC INHIBITORS OF Na+/Ca+2 EXCHANGE MECHANISM IN TREATMENT OF ARRHYTHMIA UA76168C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20011507A FI20011507A0 (fi) 2001-07-10 2001-07-10 Uusia yhdisteitä
PCT/FI2002/000621 WO2003006452A1 (en) 2001-07-10 2002-07-10 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias

Publications (1)

Publication Number Publication Date
UA76168C2 true UA76168C2 (en) 2006-07-17

Family

ID=8561628

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2004020928A UA76168C2 (en) 2001-07-10 2002-10-07 COMPOUNDS BEING DRASTIC INHIBITORS OF Na+/Ca+2 EXCHANGE MECHANISM IN TREATMENT OF ARRHYTHMIA

Country Status (27)

Country Link
US (1) US7425568B2 (enExample)
EP (1) EP1412343B1 (enExample)
JP (1) JP4113839B2 (enExample)
KR (1) KR20040025697A (enExample)
CN (1) CN1281597C (enExample)
AR (1) AR036236A1 (enExample)
AT (1) ATE338038T1 (enExample)
AU (1) AU2002321339B2 (enExample)
BR (1) BR0211070A (enExample)
CA (1) CA2452918C (enExample)
DE (1) DE60214388T2 (enExample)
DK (1) DK1412343T3 (enExample)
EA (1) EA006580B1 (enExample)
ES (1) ES2269746T3 (enExample)
FI (1) FI20011507A0 (enExample)
HR (1) HRP20040133A2 (enExample)
HU (1) HUP0400391A3 (enExample)
IL (2) IL159647A0 (enExample)
MX (1) MXPA04000267A (enExample)
NO (1) NO20035821L (enExample)
NZ (1) NZ530490A (enExample)
PL (1) PL367958A1 (enExample)
PT (1) PT1412343E (enExample)
RS (1) RS50886B (enExample)
UA (1) UA76168C2 (enExample)
WO (1) WO2003006452A1 (enExample)
ZA (1) ZA200400145B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20030030A0 (fi) 2003-01-09 2003-01-09 Orion Corp Uusia yhdisteitä
CN101137639B (zh) 2005-03-11 2012-05-23 霍华德弗洛里生理医学实验研究所 类黄酮化合物及其用途
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
RS53748B1 (sr) * 2011-09-12 2015-06-30 Sanofi Supstituisani 2-(hroman-6-iloksi)-tiazoli i njihova upotreba kao farmaceutskih sredstava
JP5941637B2 (ja) * 2011-09-12 2016-06-29 サノフイ 置換２−（クロマン−６−イルオキシ）−チアゾール及び医薬としてのその使用
AU2011376746B2 (en) * 2011-09-12 2017-06-15 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
CN102993195B (zh) * 2011-09-14 2017-05-17 赛诺菲 取代的2‑(色满‑6‑基氧基)噻唑及其作为药物的用途
CN103030646B (zh) * 2011-09-29 2016-08-24 上海恒瑞医药有限公司 苯并二氧六环类衍生物、其制备方法及其在医药上的应用
TWI633095B (zh) * 2013-03-08 2018-08-21 賽諾菲公司 經取代－６－基氧基－環烷類及其作為醫藥品之用途
GB201416186D0 (en) 2014-09-12 2014-10-29 Redx Pharma Ltd Compounds
WO2019175464A1 (en) 2018-03-14 2019-09-19 Orion Corporation Compounds useful as inhibitors of sodium-calcium exchanger (ncx)
EP4188552A2 (en) 2020-07-28 2023-06-07 Jazz Pharmaceuticals Ireland Limited Fused bicyclic raf inhibitors and methods for use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2820817A (en) 1954-02-04 1958-01-21 Mcneilab Inc Oxygenated indan compounds and method of making the same
US3862232A (en) * 1963-07-03 1975-01-21 Upjohn Co 1-(p-hydroxyphenyl)-2-phenyl-6-(2-diethylaminoethoxy)-3,4-dihydronaphthalene and the salts thereof
BE650081A (enExample) * 1963-07-03
GB1154119A (en) * 1968-05-20 1969-06-04 Merck Ag E 3-Alkyl-Flavanones
FR2733685B1 (fr) * 1995-05-05 1997-05-30 Adir Utilisation des derives du benzopyrane pour l'obtention de compositions pharmaceutiques destinees au traitement des pathologies liees a l'echangeur c1-/hc03-, na+ independant
JPH0967336A (ja) 1995-09-04 1997-03-11 Kanebo Ltd 新規なイソチオウレア誘導体
CN1166623C (zh) 1997-03-27 2004-09-15 大正制药株式会社 2-苯氧基苯胺类衍生物
JPH1149752A (ja) * 1997-08-05 1999-02-23 Taisho Pharmaceut Co Ltd フェノキシピリジン誘導体
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
EP1031556B1 (en) * 1997-10-20 2003-01-22 Taisho Pharmaceutical Co., Ltd 2-phenoxyaniline derivatives
JPH11302235A (ja) 1998-04-15 1999-11-02 Taisho Pharmaceut Co Ltd フェノキシアルキルアミン誘導体
JP2002542291A (ja) * 1999-04-23 2002-12-10 ブリストル−マイヤーズ スクイブ カンパニー ジ環式アシルグアニジン・ナトリウム／プロトン交換抑制剤および方法
WO2001021610A1 (en) 1999-09-17 2001-03-29 Nissan Chemical Industries, Ltd. Benzopyran derivative
FI20030030A0 (fi) * 2003-01-09 2003-01-09 Orion Corp Uusia yhdisteitä

Also Published As

Publication number Publication date
ATE338038T1 (de) 2006-09-15
CA2452918A1 (en) 2003-01-23
AR036236A1 (es) 2004-08-25
AU2002321339B2 (en) 2007-06-21
JP4113839B2 (ja) 2008-07-09
HUP0400391A3 (en) 2008-03-28
KR20040025697A (ko) 2004-03-24
JP2005504738A (ja) 2005-02-17
RS604A (sr) 2006-12-15
NZ530490A (en) 2005-12-23
FI20011507A0 (fi) 2001-07-10
CN1281597C (zh) 2006-10-25
NO20035821L (no) 2004-02-24
PT1412343E (pt) 2006-12-29
EA200400161A1 (ru) 2004-06-24
HRP20040133A2 (en) 2004-08-31
EP1412343A1 (en) 2004-04-28
EA006580B1 (ru) 2006-02-24
EP1412343B1 (en) 2006-08-30
IL159647A (en) 2008-04-13
DE60214388T2 (de) 2007-09-13
HK1068611A1 (en) 2005-04-29
US7425568B2 (en) 2008-09-16
MXPA04000267A (es) 2004-07-23
CA2452918C (en) 2010-02-16
WO2003006452A1 (en) 2003-01-23
BR0211070A (pt) 2004-06-15
ZA200400145B (en) 2005-04-08
HUP0400391A2 (hu) 2004-12-28
RS50886B (sr) 2010-08-31
PL367958A1 (en) 2005-03-07
ES2269746T3 (es) 2007-04-01
DK1412343T3 (da) 2007-01-02
CN1525966A (zh) 2004-09-01
US20040235905A1 (en) 2004-11-25
IL159647A0 (en) 2004-06-01
DE60214388D1 (de) 2006-10-12

Similar Documents

Publication Publication Date Title
UA76168C2 (en) COMPOUNDS BEING DRASTIC INHIBITORS OF Na+/Ca+2 EXCHANGE MECHANISM IN TREATMENT OF ARRHYTHMIA
CA1210770A (en) Leukotriene antagonists
KR20150022789A (ko) 포스포디에스테라제 억제제로서 1-페닐-2-피리디닐 알킬 알코올의 유도체
EP0394440A1 (en) Phenylcarboxylic acid derivatives
WO2013033093A1 (en) Heterocyclic compounds as janus kinase inhibitors
CZ346092A3 (en) Substituted phenyl phenol leucotriene antagonist and a pharmaceutical preparation containing thereof
RU2149158C1 (ru) Производные 2-амино-1,2,3,4-тетрагидронафталина, обладающие активностью в отношении сердечно-сосудистой системы, и фармацевтическая композиция
UA81941C2 (uk) Похідні піридину, придатні для інгібування системи обміну натрію/кальцію
AU2002321339A1 (en) New compounds, which are potent inhibitors of NA+/CA2+ exchange mechanism and are useful in the treatment of arrhythmias
RU2001911C1 (ru) Способ получени замещенных 1,2,3,4-тетрагидронафталинов или их фармацевтически приемлемых аддитивных солей кислоты
AU2014225550A1 (en) Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
WO2015001125A1 (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses
CN103073559B (zh) 手性芳香螺缩酮类化合物及其制备方法和应用
KR19990030120A (ko) 설폰아미드-치환된 크로만, 이의 제조방법, 이의 약제로서의 용도 및 이를 포함하는 약제학적 제제
US5356915A (en) Tetralones with pharmacological activity, compositions containing them
US5236935A (en) Benzopyran derivatives and processes for the preparation thereof
RU2122000C1 (ru) Бензопираны, промежуточные соединения, фармацевтическая композиция и способ лечения
RU2634698C2 (ru) Способ синтеза 6-(5-этоксигепт-1-ил)бицикло[3.3.0]октан-3-она и композиция, его содержащая
EP0773218A1 (en) N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis
WO1998015524A1 (en) Improved process for the synthesis of beta-ketonitriles
Kraouti et al. Synthesis and nematocidal activities of new analogs of pyrantel
KR100275840B1 (ko) 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄설폰아미드의 제조방법
RU2067095C1 (ru) Производные бензимидазола или их аддитивные соли с органическими или минеральными кислотами, или с минеральными или органическими основаниями, способ их получения и фармацевтическая композиция на их основе
Markaryan et al. Synthesis and antiarrhythmic properties of N-acylamino derivatives of 1, 6, 7-substituted 1, 2, 3, 4-tetrahydroisoquinoline-4-spirocyclopentanes and their analogs
NZ212387A (en) N-substituted-4-substituted-trans decahydroquinoline derivatives, and pharmaceutical compositions containing such